A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle

BMJL Mannaerts; study gr The ganirelix dose finding; D (Diederick) de Jong; BCJM (Bart) Fauser

A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle

BMJL Mannaerts
, study gr The ganirelix dose finding
, D (Diederick) de Jong
, BCJM (Bart) Fauser

Obstetrics & Gynecology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	3023-3031
Number of pages	9
Journal	Human Reproduction
Volume	13
Issue number	11
Publication status	Published - 1998

Research programs

EMC MM-01-52-07

Cite this

Mannaerts, BMJL., The ganirelix dose finding, S. G., de Jong, D., & Fauser, BCJM. (1998). A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle. Human Reproduction, 13(11), 3023-3031.

Mannaerts, BMJL ; The ganirelix dose finding, study gr ; de Jong, D (Diederick) et al. / A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle. In: Human Reproduction. 1998 ; Vol. 13, No. 11. pp. 3023-3031.

@article{4da01b76da8547d095e964a9615f2a87,

title = "A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle",

author = "BMJL Mannaerts and \{The ganirelix dose finding\}, \{study gr\} and \{de Jong\}, \{D (Diederick)\} and Fauser, \{BCJM (Bart)\}",

year = "1998",

language = "Undefined/Unknown",

volume = "13",

pages = "3023--3031",

journal = "Human Reproduction",

issn = "0268-1161",

publisher = "Oxford University Press",

number = "11",

}

Mannaerts, BMJL, The ganirelix dose finding, SG, de Jong, D & Fauser, BCJM 1998, 'A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle', Human Reproduction, vol. 13, no. 11, pp. 3023-3031.

A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle. / Mannaerts, BMJL; The ganirelix dose finding, study gr; de Jong, D (Diederick) et al.
In: Human Reproduction, Vol. 13, No. 11, 1998, p. 3023-3031.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle

AU - Mannaerts, BMJL

AU - The ganirelix dose finding, study gr

AU - de Jong, D (Diederick)

AU - Fauser, BCJM (Bart)

PY - 1998

Y1 - 1998

M3 - Article

SN - 0268-1161

VL - 13

SP - 3023

EP - 3031

JO - Human Reproduction

JF - Human Reproduction

IS - 11

ER -

Mannaerts BMJL, The ganirelix dose finding SG, de Jong D, Fauser BCJM. A double -blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antgonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle. Human Reproduction. 1998;13(11):3023-3031.